Abbott Laboratories

There are several major flaws in the classic "retirement as a goal" scenario, but you're not locked into it. If you've avoided major debt and have an education that allows you the freedom to re-imagine the concept, you could completely change your life.

Abbott Laboratories is recalling roughly 359 million blood-sugar test strips for diabetics after the strips turned out to yield falsely low readings.

If you've experienced sticker shock at the pharmacy and wondered why drug prices are always rising, even for generics, consider the value of salt. Baxter International, which sells drugs to health care providers and pharmacies, billed Medicaid $928 for $1.71 worth of saline solution -- a 54,000%...

Abbott Laboratories agreed to withdraw diet drug Meridia, after clinical trial data concluded that the drug increased the risk of heart attack and stroke and did little to help people lose weight. The Food and Drug Administration announced the recall of Meridia, which has become a highly-popular...

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

Abbott has recalled 5 million containers of its top-selling powdered baby formula, Similac, after finding beetles at one of its factories. But parents shouldn't panic, the company says. The chances that any beetlejuice actually made it into the formula is slim, and doctors say babies wouldn't be harmed even if it did.

Abbott Laboratories is recalling 5 million containers of its best-selling Similac infant formula over concerns that the powdered formulas are contaminated by insect parts or larvae, the company said. Abbott said a beetle was found in the production area of a manufacturing facility and says it...

Giant U.S. pharmaceutical group Abbott Laboratories is cutting 3,000 jobs, or about 3% of its workforce, following its purchase of Belgian-based Solvay's drugs business.

The New England Journal of Medicine called Meridia "another flawed diet pill" -- two weeks before government advisers are scheduled to review the drug -- after a study finds it raises the risk of heart attack and stroke in users with heart problems.

The Feds -- and consumers -- may finally have had it with 'pay-for-delay.' In these deals, generic drug companies that challenge a patent held by a name-brand pharmaceuticals agree to settle by delaying their entry into the market in return for a payment. But regulators are now calling for laws to end the practice.